Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title NUCALA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PROLIA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title APRETUDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CABENUVA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title MIRTAZAPINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RAMIPRIL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title APIXABAN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LEVETIRACETAM
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUVYZAT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HUMAN IMMUNOGLOBULIN G
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CEFOXITIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title KESIMPTA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OTEZLA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUPLAZID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ADALIMUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DENOSUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PANTOPRAZOLE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DURVALUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HYDROCHLOROTHIAZIDE\LOSARTAN POTASSIUM
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND KWIKPEN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TRULICITY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title KISUNLA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FOUNDAYO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND KWIKPEN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title INFLIXIMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CILTACABTAGENE AUTOLEUCEL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology